New pill versions of weight loss drugs, lower prices, and patent expirations will all drive GLP-1 demand in 2026 ...
The weight-loss drug eloralintide shows up to 20% body weight reduction in trial, offering hope for obesity treatment beyond ...
Trial participants who used eloralintide, a new weight loss medication that, instead of focusing on the hormone GLP-1, ...
Semaglutide, the drug behind weight-loss jabs Ozempic and Wegovy, does not slow cognitive decline among people with ...
The drug tested was Rybelsus, a pill approved only for type 2 diabetes. Like Novo's blockbusters Ozempic and Wegovy, it ...
The pharma giant said amycretin helped patients lose weight and reduce blood-sugar levels in pill and injection forms during ...